140 related articles for article (PubMed ID: 9870724)
21. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
[TBL] [Abstract][Full Text] [Related]
22. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.
Meric F; Mirza NQ; Buzdar AU; Hunt KK; Ames FC; Ross MI; Pollock RE; Newman LA; Feig BW; Strom EA; Buchholz TA; McNeese MD; Hortobagyi GN; Singletary SE
Ann Surg Oncol; 2000 Jul; 7(6):435-40. PubMed ID: 10894139
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
FitzSullivan E; Bassett RL; Kuerer HM; Mittendorf EA; Yi M; Hunt KK; Babiera GV; Caudle AS; Black DM; Bedrosian I; Reyna C; Teshome M; Meric-Bernstam F; Hwang R
Ann Surg Oncol; 2017 Mar; 24(3):652-659. PubMed ID: 27822630
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
26. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
27. Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?
Marinko T; Stanic K
Radiol Oncol; 2018 Mar; 52(3):275-280. PubMed ID: 30210045
[TBL] [Abstract][Full Text] [Related]
28. Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
Ejlertsen B; Offersen BV; Overgaard J; Christiansen P; Jensen MB; Kroman N; Knoop AS; Mouridsen H
Acta Oncol; 2018 Jan; 57(1):3-12. PubMed ID: 29205077
[TBL] [Abstract][Full Text] [Related]
29. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
[TBL] [Abstract][Full Text] [Related]
30. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
[TBL] [Abstract][Full Text] [Related]
31. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM
Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
[TBL] [Abstract][Full Text] [Related]
32. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
33. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
[TBL] [Abstract][Full Text] [Related]
34. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
[TBL] [Abstract][Full Text] [Related]
35. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer.
Janjan NA; Murray KJ; Conway P; Walker A; Wilson JF
Cancer; 1992 Jun; 69(11):2842-8. PubMed ID: 1571915
[TBL] [Abstract][Full Text] [Related]
36. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG).
Axelsson CK; Mouridsen HT; Zedeler K
Eur J Cancer; 1992; 28A(8-9):1415-8. PubMed ID: 1515262
[TBL] [Abstract][Full Text] [Related]
37. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study.
Tvedskov TF; Jensen MB; Ejlertsen B; Christiansen P; Balslev E; Kroman N
Breast Cancer Res Treat; 2015 Oct; 153(3):599-606. PubMed ID: 26341752
[TBL] [Abstract][Full Text] [Related]
39. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.
Stranzl H; Mayer R; Ofner P; Peintinger F; Prettenhofer U; Hackl A
Strahlenther Onkol; 2004 Jan; 180(1):31-7. PubMed ID: 14704842
[TBL] [Abstract][Full Text] [Related]
40. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
